End Stage Renal Disease (ESRD)

Nephrology
0
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Medical Components
Medical ComponentsPA - Harleysville
1 program
PD Catheter groupN/A1 trial
Active Trials
NCT02274896Withdrawn0Est. Dec 2015
Outset Medical
Outset MedicalSAN JOSE, CA
1 program
Tablo Hemodialysis SystemN/A1 trial
Active Trials
NCT04912050Completed33Est. May 2022
Rockwell Medical
1 program
soluble ferric pyrophosphateN/A1 trial
Active Trials
NCT00604565TerminatedEst. Dec 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Outset MedicalTablo Hemodialysis System
Medical ComponentsPD Catheter group
Rockwell Medicalsoluble ferric pyrophosphate

Clinical Trials (3)

Total enrollment: 33 patients across 3 trials

NCT04912050Outset MedicalTablo Hemodialysis System

EXtension of Tablo TrEatmeNt Duration Registry

Start: May 2021Est. completion: May 202233 patients
N/ACompleted

Bayston Multicenter Antimicrobial PD Catheter Safety Study

Start: Nov 2014Est. completion: Dec 20150
N/AWithdrawn
NCT00604565Rockwell Medicalsoluble ferric pyrophosphate

Delivery of Soluble Ferric Pyrophosphate (SFP) Via the Dialysate to Maintain Iron Balance in Hemodialysis Patients

Start: Jan 2008Est. completion: Dec 2010
N/ATerminated

Related Jobs in Nephrology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space